SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19

India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19

05/09/2021 23:24
India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19

- Indian drugmaker Cipla Ltd CIPL.NS said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co LLY.N to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.


(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Rashmi Aich)

(([email protected]; +91 99863 58469;))